IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX - Nasdaq - BMG4690M1010 - Common Stock - Currency: USD
Taking everything into account, IBEX scores 6 out of 10 in our fundamental rating. IBEX was compared to 82 industry peers in the IT Services industry. IBEX has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on IBEX. With these ratings, IBEX could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
IBEX had a positive operating cash flow in the past year.
Each year in the past 5 years IBEX has been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
IBEX's Return On Assets of 13.56% is amongst the best of the industry. IBEX outperforms 92.31% of its industry peers.
IBEX's Return On Equity of 33.92% is amongst the best of the industry. IBEX outperforms 93.59% of its industry peers.
IBEX has a better Return On Invested Capital (19.86%) than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.56% | ||
| ROE | 33.92% | ||
| ROIC | 19.86% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of IBEX (7.08%) is better than 66.67% of its industry peers.
IBEX's Profit Margin has improved in the last couple of years.
IBEX has a better Operating Margin (9.22%) than 67.95% of its industry peers.
In the last couple of years the Operating Margin of IBEX has grown nicely.
IBEX has a Gross Margin of 30.76%. This is comparable to the rest of the industry: IBEX outperforms 42.31% of its industry peers.
IBEX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.22% | ||
| PM (TTM) | 7.08% | ||
| GM | 30.76% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
IBEX has an Altman-Z score of 3.96. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.96, IBEX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
IBEX has a debt to FCF ratio of 1.31. This is a very positive value and a sign of high solvency as it would only need 1.31 years to pay back of all of its debts.
The Debt to FCF ratio of IBEX (1.31) is better than 75.64% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that IBEX is not too dependend on debt financing.
IBEX has a Debt to Equity ratio (0.30) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.31 | ||
| Altman-Z | 3.96 |
ROIC/WACC1.88
WACC10.58%
2.3 Liquidity
IBEX has a Current Ratio of 1.44. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, IBEX is in line with its industry, outperforming 44.87% of the companies in the same industry.
IBEX has a Quick Ratio of 1.44. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.44, IBEX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 35.80% over the past year.
The Earnings Per Share has been growing by 25.59% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.67% in the past year.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.66% yearly.
EPS 1Y (TTM)35.8%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%34.09%
Revenue 1Y (TTM)1.67%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%6.07%
3.2 Future
The Earnings Per Share is expected to grow by 18.73% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.57% on average over the next years.
EPS Next Y21.73%
EPS Next 2Y18.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.85%
Revenue Next 2Y4.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.42, the valuation of IBEX can be described as reasonable.
Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
IBEX is valuated cheaply when we compare the Price/Earnings ratio to 29.98, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.33, the valuation of IBEX can be described as very reasonable.
Based on the Price/Forward Earnings ratio, IBEX is valued cheaper than 94.87% of the companies in the same industry.
IBEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.66.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.42 | ||
| Fwd PE | 8.33 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBEX is valued cheaper than 92.31% of the companies in the same industry.
IBEX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IBEX is cheaper than 89.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.68 | ||
| EV/EBITDA | 4.76 |
4.3 Compensation for Growth
IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IBEX may justify a higher PE ratio.
A more expensive valuation may be justified as IBEX's earnings are expected to grow with 18.73% in the coming years.
PEG (NY)0.48
PEG (5Y)0.41
EPS Next 2Y18.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.9
-0.41 (-1.62%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners83.79%
Inst Owner Change-32.97%
Ins Owners10.11%
Ins Owner Change-139.51%
Market Cap328.43M
Analysts82.5
Price Target26.52 (6.51%)
Short Float %0.97%
Short Ratio0.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.93%
Min EPS beat(2)7.33%
Max EPS beat(2)14.54%
EPS beat(4)4
Avg EPS beat(4)15.54%
Min EPS beat(4)7.33%
Max EPS beat(4)31.98%
EPS beat(8)6
Avg EPS beat(8)9%
EPS beat(12)9
Avg EPS beat(12)15.24%
EPS beat(16)11
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)2.01%
Min Revenue beat(2)1.58%
Max Revenue beat(2)2.45%
Revenue beat(4)2
Avg Revenue beat(4)0.45%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)2.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.88%
Revenue beat(12)3
Avg Revenue beat(12)-1.9%
Revenue beat(16)4
Avg Revenue beat(16)-1.89%
PT rev (1m)10.64%
PT rev (3m)10.64%
EPS NQ rev (1m)5.84%
EPS NQ rev (3m)5.84%
EPS NY rev (1m)4.98%
EPS NY rev (3m)4.98%
Revenue NQ rev (1m)1.12%
Revenue NQ rev (3m)1.12%
Revenue NY rev (1m)1.5%
Revenue NY rev (3m)1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.42 | ||
| Fwd PE | 8.33 | ||
| P/S | 0.63 | ||
| P/FCF | 12.68 | ||
| P/OCF | 8.7 | ||
| P/B | 3.01 | ||
| P/tB | 3.38 | ||
| EV/EBITDA | 4.76 |
EPS(TTM)2.39
EY9.6%
EPS(NY)2.99
Fwd EY12%
FCF(TTM)1.96
FCFY7.88%
OCF(TTM)2.86
OCFY11.5%
SpS39.55
BVpS8.26
TBVpS7.36
PEG (NY)0.48
PEG (5Y)0.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.56% | ||
| ROE | 33.92% | ||
| ROCE | 29.72% | ||
| ROIC | 19.86% | ||
| ROICexc | 22.17% | ||
| ROICexgc | 23.79% | ||
| OM | 9.22% | ||
| PM (TTM) | 7.08% | ||
| GM | 30.76% | ||
| FCFM | 4.96% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.31 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 65.42% | ||
| Cap/Sales | 2.27% | ||
| Interest Coverage | 44.5 | ||
| Cash Conversion | 57.01% | ||
| Profit Quality | 70.08% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 3.96 |
F-Score6
WACC10.58%
ROIC/WACC1.88
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.8%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%34.09%
EPS Next Y21.73%
EPS Next 2Y18.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.67%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%6.07%
Revenue Next Year4.85%
Revenue Next 2Y4.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.62%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year83.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.31%
OCF growth 3Y30.7%
OCF growth 5Y74.8%